Squarepoint
HRMY icon

Squarepoint’s Harmony Biosciences HRMY Stock Holding History

Squarepoint’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
41,100
+2,100
+5% +$68.9K ﹤0.01% 2653
2025
Q4 		$1.46M Hold
39,000
– – ﹤0.01% 2295
2025
Q3 		$1.07M Hold
39,000
– – ﹤0.01% 2630
2025
Q2 		$1.23M Sell
39,000
-8,889
-19% -$286K ﹤0.01% 2488
2025
Q1 		$1.59M Buy
47,889
+30,988
+183% +$1.11M ﹤0.01% 2281
2024
Q4 		$582K Buy
16,901
+9,411
+126% +$323K ﹤0.01% 3606
2024
Q3 		$300K Sell
7,490
-42,527
-85% -$1.49M ﹤0.01% 3447
2024
Q2 		$1.51M Buy
+50,017
New +$1.5M ﹤0.01% 2259
2023
Q2 		– Sell
-17,339
Closed -$566K – 3745
2023
Q1 		$566K Sell
17,339
-60,623
-78% -$2.76M ﹤0.01% 2232
2022
Q4 		$4.3M Buy
77,962
+30,783
+65% +$1.69M 0.02% 917
2022
Q3 		$2.09M Buy
47,179
+11,112
+31% +$542K 0.01% 1296
2022
Q2 		$1.76M Sell
36,067
-13,904
-28% -$626K 0.01% 1279
2022
Q1 		$2.43M Buy
49,971
+10,720
+27% +$437K 0.01% 1043
2021
Q4 		$1.67M Buy
+39,251
New +$1.56M ﹤0.01% 1365
2021
Q3 		– Sell
-38,041
Closed -$1.07M – 3135
2021
Q2 		$1.07M Buy
+38,041
New +$1.14M ﹤0.01% 1576
2020
Q4 		– Sell
-10,461
Closed -$355K – 3058
2020
Q3 		$355K Buy
+10,461
New +$381K ﹤0.01% 1677

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Squarepoint's HRMY Position: Q1 2026 in Review

Squarepoint increased its Harmony Biosciences (HRMY) stake by 5.4% in Q1 2026, buying an estimated $68.9K and bringing the position to 41,100 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

Squarepoint first reported a position in HRMY in Q3 2020 and has held it in 16 quarters since. The position peaked at $4.3M in Q4 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Squarepoint held 41,100 shares of Harmony Biosciences worth $1.15M as of Q1 2026.
  • Squarepoint bought 2,100 Harmony Biosciences shares in Q1 2026, an estimated $68.9K.
  • Harmony Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2653 holding.
  • Squarepoint first reported a position in Harmony Biosciences in Q3 2020 and has held it in 16 quarters since.
  • Squarepoint's Harmony Biosciences position peaked at $4.3M in Q4 2022.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.